Review on Neuropharmacy and Cognitive Enhancer

Abstract

In the modern era of constant stress and competitive lifestyles, the prevalence of neurodegenerative and cognitive disorders has increased substantially, emphasizing the urgent need for neuroprotective and cognition-enhancing agents. Neuropharmacology explores the interaction between drugs and the nervous system to develop therapies that improve neuronal communication, memory, and learning. Cognitive enhancers, or nootropics, represent a diverse group of compounds capable of enhancing mental performance, learning, attention, and memory. These may act through neurotransmitter modulation, neuroprotection, or improvement in cerebral metabolism and blood flow. The review comprehensively discusses natural and synthetic nootropics, their pharmacological mechanisms, therapeutic indications, and comparative advantages. Natural agents such as Withania somnifera (Ashwagandha), Bacopa monnieri (Brahmi), Ginkgo biloba, Huperzia serrata, and Celastrus paniculatus demonstrate promising neuroprotective and antioxidant effects with lower toxicity, whereas synthetic compounds like piracetam, memantine, and D-cycloserine act through neurotransmitter systems such as cholinergic, dopaminergic, and glutamatergic pathways. The review also highlights ethical, legal, and safety considerations associated with the non-medical use of cognitive enhancers. With ongoing advancements in neuropharmacology, future therapeutic strategies—including gene targeting, stem cell therapy, and neurotrophic factor modulation—offer hope for managing cognitive decline. Collectively, neuropharmacy bridges the gap between pharmacological research and the quest for improved cognitive well-being, underscoring the importance of safe and rational use of both natural and synthetic nootropics.[90]